Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.

Saved in:
Bibliographic Details
Title: Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Authors: Bressler NM, Bressler SB, Haynes LA, Hao Y, Kaiser PK, Miller JW, Naor J, Potter MJ, Pournaras CJ, Reaves A, Rosenfeld PJ, Schmidt-Erfurth U, Slakter JS, Strong A, Vannier S
Source: Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2005 Sep; Vol. 123 (9), pp. 1283-5.
Publication Type: Clinical Trial; Letter; Randomized Controlled Trial; Comment
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited Medium: Print ISSN: 0003-9950 (Print) Linking ISSN: 00039950 NLM ISO Abbreviation: Arch Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0003-9950
DOI:10.1001/archopht.123.9.1283